Measuring cardiomyocyte cellular characteristics in cardiac hypertrophy using diffusion-weighted MRI

Measuring cardiomyocyte cellular characteristics in cardiac hypertrophy using diffusion-weighted MRI

<p><strong>Purpose:</strong> This paper presents a hierarchical modeling approach for estimatingcardiomyocyte major and minor diameters and intracellular volume fraction(ICV) using diffusion-weighted MRI (DWI) data in ex vivo mouse hearts.</p> <p><strong>Methods:&...

Full description

Bibliographic Details
Main Authors:	Farzi, M, Coveney, S, Afzali, M, Zdora, M-C, Lygate, CA, Rau, C, Frangi, AF, Dall'Armellina, E, Teh, I, Schneider, JE
Format:	Journal article
Language:	English
Published:	Wiley 2023

Similar Items

Assessing myocardial microstructure with biophysical models of diffusion MRI
by: Farzi, M, et al.
Published: (2021)

Improved method for quantification of regional cardiac function in mice using phase-contrast MRI.
by: Dall'Armellina, E, et al.
Published: (2012)

Improved method for quantification of regional cardiac function in mice using phase-contrast MRI
by: Dall'Armellina, E, et al.
Published: (2012)

Flow vortices in the aortic root: in vivo 4D-MRI confirms predictions of Leonardo da Vinci.
by: Bissell, M, et al.
Published: (2014)

Validation of diffusion tensor MRI measurements of cardiac microstructure with structure tensor synchrotron radiation imaging
by: Teh, I, et al.
Published: (2017)

MRI based non-invasive detection of cardiomyocyte hypertrophy and cell-volume changes
by: Coelho-Filho Otavio R, et al.
Published: (2012-02-01)

A comprehensive quantitative comparison of myocardial motion in mice, rabbits and humans using phase contrast MRI.
by: Jung, B, et al.
Published: (2012)

Correction of slice misalignment in multi-breath-hold cardiac MRI scans
by: Villard, B, et al.
Published: (2017)

From recognized to novel quantitative CMR biomarkers of LV recovery: a paradigm shift in acute myocardial infarction imaging
by: Dall'Armellina, E
Published: (2016)

Applications of 3 Tesla CMR in acute coronary syndromes (ACS)
by: Dall'Armellina, E
Published: (2012)

Quels espaces pour des écritures créatives numériques ?
by: Luc Dall’Armellina

Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced Hypertrophy
by: Kamilla Gömöri, et al.
Published: (2022-11-01)

Assessment of blood flow and valvular heart disease using phase-contrast cardiovascular magnetic resonance.
by: Dall'Armellina, E, et al.
Published: (2007)

Metabolic remodelling in hypertrophied and failing myocardium: a review
by: Peterzan, M, et al.
Published: (2017)

T1 Mapping in Ischemic Heart Disease
by: Dall'Armellina, E, et al.
Published: (2014)

Surgical models of hypertrophy and heart failure: Myocardial infarction and transverse aortic constriction
by: Lygate, C
Published: (2006)

Cardiomyocytes from Creatine-Deficient Mice Lacking L-Arginine: Glycine Amidinotransferase (AGAT) Show No Changes in Mitochondrial Organization and Cellular Compartmentation
by: Kotlyarova, S, et al.
Published: (2013)

Identification of hypertrophy-modulating Cullin-RING ubiquitin ligases in primary cardiomyocytes
by: Maximillian Fischer, et al.
Published: (2023-03-01)

Inhibition of Cardiomyocytes Hypertrophy by Resveratrol Is Associated with Amelioration of Endoplasmic Reticulum Stress
by: Yan Lin, et al.
Published: (2016-07-01)

Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
by: Ai-Lan Chen, et al.
Published: (2012-12-01)

Hypertrophy-Reduced Autophagy Causes Cardiac Dysfunction by Directly Impacting Cardiomyocyte Contractility
by: Christiane Ott, et al.
Published: (2021-04-01)

CMR for characterization of the myocardium in acute coronary syndromes.
by: Dall'Armellina, E, et al.
Published: (2010)

Ischemic heart disease: Comprehensive evaluation by cardiovascular magnetic resonance
by: Karamitsos, T, et al.
Published: (2011)

Ischemic heart disease: comprehensive evaluation by cardiovascular magnetic resonance.
by: Karamitsos, T, et al.
Published: (2011)

GSK3β Serine 389 Phosphorylation Modulates Cardiomyocyte Hypertrophy and Ischemic Injury
by: Laura Vainio, et al.
Published: (2021-12-01)

Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy
by: Chang Youn Lee, et al.
Published: (2020-11-01)

Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts
by: Sanford P. Bishop, et al.
Published: (2022-06-01)

Fibin regulates cardiomyocyte hypertrophy and causes protein-aggregate-associated cardiomyopathy in vivo
by: Matthias Petersen, et al.
Published: (2023-06-01)

Early Dynamic Changes in 'Salvaged Area at Risk' Assessed by Serial MRI at 3t in Patients With Acute Coronary Syndrome
by: Dall'Armellina, E, et al.
Published: (2009)

THE DETECTION OF ACUTE MYOCARDITIS USING CARDIOVASCULAR MRI: A CLINICAL STUDY COMPARING T1-MAPPING, T2-WEIGHTED AND LATE GADOLINIUM ENHANCEMENT IMAGING
by: Ferreira, V, et al.
Published: (2013)

Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy
by: Moritz Meyer-Jens, et al.
Published: (2024-03-01)

Changes in glutamic oxaloacetic transaminase 2 during rat physiological and pathological cardiomyocyte hypertrophy
by: Xin Liu, et al.
Published: (2023-12-01)

Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
by: Masafumi Funamoto, et al.
Published: (2022-06-01)

Cardioprotective effects of Moku-boi-to and its impact on AngII-induced cardiomyocyte hypertrophy
by: Hideaki Tagashira, et al.
Published: (2023-11-01)

Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy.
by: Carolina Fernández, et al.
Published: (2021-01-01)

EPC-derived microvesicles protect cardiomyocytes from Ang II-induced hypertrophy and apoptosis.
by: Shenhong Gu, et al.
Published: (2014-01-01)

TRPC5-eNOS Axis Negatively Regulates ATP-Induced Cardiomyocyte Hypertrophy
by: Caroline Sunggip, et al.
Published: (2018-05-01)

A quantitative comparison of regional myocardial motion in mice, rabbits and humans using in-vivo phase contrast CMR.
by: Jung, B, et al.
Published: (2012)

Transcriptomics reveal stretched human pluripotent stem cell-derived cardiomyocytes as an advantageous hypertrophy model
by: Lotta Pohjolainen, et al.
Published: (2022-12-01)

Epigenome-wide DNA methylation profiling in comparison between pathological and physiological hypertrophy of human cardiomyocytes
by: Hangchuan Shi, et al.
Published: (2023-09-01)